Gileap Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 02-06-2024
- Paid Up Capital ₹ 0.10 M
as on 02-06-2024
- Company Age 6 Year, 16 Days
- Last Filing with ROC 31 Mar 2020
- Revenue %
(FY 2020)
- Profit -752.50%
(FY 2020)
- Ebitda -791.40%
(FY 2020)
- Net Worth -757.69%
(FY 2020)
- Total Assets 450.89%
(FY 2020)
About Gileap Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Satya Prakash and Rajneesh Verma serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC317979
- Company No.
317979
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2018
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gileap Pharmaceutical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satya Prakash  | Director | 07-Dec-2018 | Current |
| Rajneesh Verma | Director | 07-Dec-2018 | Current |
Financial Performance of Gileap Pharmaceutical.
Gileap Pharmaceutical Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 752.5% decrease in profit. The company's net worth observed a substantial decline by a decrease of 757.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gileap Pharmaceutical?
Unlock access to Gileap Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gileap Pharmaceutical?
Unlock and access historical data on people associated with Gileap Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gileap Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gileap Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
